ALPS Global Holding Berhad
Malaysia-headquartered biotechnology and life-sciences organisation operating integrated capabilities across GMP cell manufacturing, molecular diagnostics, clinical services and wellness. The group provides clinical-grade genomic and mRNA testing, develops cell-based immunotherapies and regenerative medicine approaches, operates ISO-accredited molecular laboratories, and maintains a portfolio of patents and scientific publications.
Industries
Nr. of Employees
medium (51-250)
ALPS Global Holding Berhad
Services
Research, development and provision of cell-based therapies and immunotherapies including mesenchymal and induced pluripotent stem cell approaches and natural killer cell methods, supported by in-house GMP manufacturing.
Clinical-grade genomic and gene expression testing services including whole genome, exome, targeted sequencing and mRNA profiling performed in an accredited molecular laboratory.
Routine and specialised clinical laboratory tests including biochemistry, serology, immunology and haematology to support diagnostics and health screening.
Microbiological testing for product quality, environmental monitoring and contamination assessment across pharmaceutical, food & beverage and related industries.
On-site health screening packages and non-surgical aesthetic procedures including preventive screening, tumour marker panels and lifestyle consultations.
Formation of strategic cooperation agreements and joint investment projects to develop medical and health tourism infrastructure, research institutions and related services.
Research, development and provision of cell-based therapies and immunotherapies including mesenchymal and induced pluripotent stem cell approaches and natural killer cell methods, supported by in-house GMP manufacturing.
Clinical-grade genomic and gene expression testing services including whole genome, exome, targeted sequencing and mRNA profiling performed in an accredited molecular laboratory.
Routine and specialised clinical laboratory tests including biochemistry, serology, immunology and haematology to support diagnostics and health screening.
Microbiological testing for product quality, environmental monitoring and contamination assessment across pharmaceutical, food & beverage and related industries.
On-site health screening packages and non-surgical aesthetic procedures including preventive screening, tumour marker panels and lifestyle consultations.
Formation of strategic cooperation agreements and joint investment projects to develop medical and health tourism infrastructure, research institutions and related services.
Expertise Areas
- Cell therapy development and GMP manufacturing
- Clinical trial execution and large-scale clinical data collection
- Clinical genomics and molecular diagnostics
- In vitro assay development and bioanalytics
Key Technologies
- Whole genome sequencing (WGS)
- Whole exome sequencing (WES)
- Targeted sequencing
- mRNA expression profiling
News & Updates
Report on strategic cooperation agreements and joint investment plans to develop medical and health tourism infrastructure and research collaborations with regional partners.
Coverage of a startup showcase event highlighting participation in the Pitch Malaysia USA Series and several memorandum of understanding signings involving regional partners and startups.
Summary of pitching sessions and investor roundtables where regional startups engaged with venture capital representatives and accelerator operators.
Account of pitching sessions attended by startups and meetings with multiple venture capital firms and advisors during investor outreach events.
Report on startup exhibitions and business meetings with US government and investment representatives during an international investment summit.
Company profile and strategic pivot toward expanding access to biotechnology services following a Nasdaq listing.
Report on strategic cooperation agreements and joint investment plans to develop medical and health tourism infrastructure and research collaborations with regional partners.
Coverage of a startup showcase event highlighting participation in the Pitch Malaysia USA Series and several memorandum of understanding signings involving regional partners and startups.
Summary of pitching sessions and investor roundtables where regional startups engaged with venture capital representatives and accelerator operators.
Account of pitching sessions attended by startups and meetings with multiple venture capital firms and advisors during investor outreach events.
Report on startup exhibitions and business meetings with US government and investment representatives during an international investment summit.
Company profile and strategic pivot toward expanding access to biotechnology services following a Nasdaq listing.